CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Long Island Consultation Center

Long Island Consultation Center is a Rego Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cornerstone Eye Associates

Cornerstone Eye Associates is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Comaiba

Comaiba is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brook Health

Get personalized guidance and chat with live health experts any day of the year to help manage or prevent diabetes, lose weight, and boost energy levels

David Thompson Health Region

David Thompson Health Region is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. David Thompson Health Region is based in Norglenwold, AB. You can find more information on David Thompson Health Region at www.dthr.ab.ca